Immunotherapy: New Era for NSCLC Management – Medscape
Medscape |
Immunotherapy: New Era for NSCLC Management
Medscape It is not often that "a new standard of care" or "remarkable" are bandied about to describe study results for novel compounds, but this is exactly what happened when trial data on immunotherapies for lung cancer were released last fall. |
